financetom
Business
financetom
/
Business
/
Form 8.3 - Alpha Group International plc
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3 - Alpha Group International plc
Sep 17, 2025 10:18 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Millennium International Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Alpha Group International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

16th September 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

0.2p Ordinary (GB00BF1TM596)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

-

 

-

 

-

 

-

(2) Cash-settled derivatives:

 

 

806,685

 

1.907%

 

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

-

-

 

TOTAL:

 

806,685

 

1.907%

 

-

-

-

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/sale

 

 

Number of securities

 

Price per unit (GBP)

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

 

GB00BF1TM596

 

Equity Swap

 

Reducing a long Position

 

8

 

41.80 GBP

GB00BF1TM596

 

Equity Swap

 

Increasing a long Position

 

21,667

 

41.87 GBP

GB00BF1TM596

 

Equity Swap

 

Reducing a long Position

 

2,162

 

41.80 GBP

GB00BF1TM596

 

Equity Swap

 

Increasing a long Position

 

55

 

41.85 GBP

GB00BF1TM596

 

Equity Swap

 

Increasing a long Position

 

733

 

41.82 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(c) Attachments

Class of relevant security:

 

0.2p Ordinary (GB00BF1TM596)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

-

 

-

 

-

 

-

(2) Cash-settled derivatives:

 

 

806,685

 

1.907%

 

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

-

-

 

TOTAL:

 

806,685

 

1.907%

 

-

-

-

0

Class of relevant security:

 

0.2p Ordinary (GB00BF1TM596)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

-

 

-

 

-

 

-

(2) Cash-settled derivatives:

 

 

806,685

 

1.907%

 

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

-

-

 

TOTAL:

 

806,685

 

1.907%

 

-

-

-

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Millennium Partners, L.P.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tenon Medical Q3 revenue up 32% but misses estimates
Tenon Medical Q3 revenue up 32% but misses estimates
Nov 13, 2025
Overview * Tenon Medical ( TNON ) Q3 revenue grows 32% yr/yr to $1.17 mln, missing analysts' expectations * Net loss for Q3 2025 was $3.3 mln, slightly higher than Q3 2024 * Company raised $2.85 mln in PIPE financing post-Q3 to fund growth Outlook * Company plans SImmetry+ alpha launch in Q4 2025 * Tenon Medical ( TNON )...
Digital publisher Arena Group's Q3 net income misses estimates
Digital publisher Arena Group's Q3 net income misses estimates
Nov 13, 2025
Overview * Arena Group Q3 2025 revenue declined, missing analyst expectations * Net income for Q3 2025 rose 73% yr/yr but missed analyst estimates * Adjusted EBITDA for Q3 2025 increased by 6.3% over Q3 2024 Outlook * Company emphasizes growth in data, AI, and e-commerce as future drivers * Arena Group ( AREN ) highlights audience volatility as a...
Biopharmaceutical company Precigen Q3 net loss widens 
Biopharmaceutical company Precigen Q3 net loss widens 
Nov 13, 2025
Overview * Precigen ( PGEN ) Q3 net loss widens significantly due to non-cash items like warrant liabilities * PAPZIMEOS receives FDA approval, launches as first treatment for adults with RRP * Company advances PAPZIMEOS commercialization with over 90% target institutions engaged * Cash, cash equivalents, and investments totaled $123.6 million as of September 30, 2025 Outlook * Company expects...
SeaStar Medical Q3 net loss narrows
SeaStar Medical Q3 net loss narrows
Nov 13, 2025
Overview * SeaStar Medical ( ICU ) Q3 net loss narrows to $3.5 mln from $4.5 mln year-over-year * Company raised $12.4 mln to strengthen balance sheet and fund future operations * SeaStar Medical ( ICU ) expands QUELIMMUNE therapy to three new top-rated children's hospitals Outlook * Company raised $12.4 mln to support future operations * SeaStar Medical (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved